The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review
暂无分享,去创建一个
[1] V. Rohde,et al. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience , 2010, Neurosurgical Review.
[2] L. Capelle,et al. Biodegradable Carmustine Wafers (Gliadel) Alone or in Combination with Chemoradiotherapy: The French Experience , 2010, Annals of Surgical Oncology.
[3] V. Rohde,et al. Risk Management in the Treatment of Malignant Gliomas with BCNU Wafer Implants , 2010, Central European neurosurgery.
[4] P. Boyer,et al. Adding Biodegradable Carmustine Wafers before a Stupp Schedule Does Not Alter Outcome of Patients with High Grade Brain Tumor , 2009 .
[5] D. Bigner,et al. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy , 2009, Cancer.
[6] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[7] Martin Glas,et al. Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] A. Brandes,et al. Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] M. McGirt,et al. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. , 2009, Journal of neurosurgery.
[10] R. McLendon,et al. Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme , 2009, Clinical Cancer Research.
[11] H. Maximilian Mehdorn,et al. Localized BCNU chemotherapy and the multimodal management of malignant glioma , 2009 .
[12] M. McGirt,et al. Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience , 2008, Annals of Surgical Oncology.
[13] Brian J. Smith,et al. Treatment of adults with newly diagnosed glioblastoma multiforme or anaplastic astrocytoma with surgery, gliadel wafers and limited field radiation plus concomitant temozolomide followed by adjuvant temozolomide , 2008 .
[14] E. Pan,et al. A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients , 2008, Journal of Neuro-Oncology.
[15] R. Martuza,et al. The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma , 2008, Journal of Neuro-Oncology.
[16] I. Whittle,et al. Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years? , 2008, British journal of neurosurgery.
[17] Z. Ram,et al. Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial , 2006, Acta Neurochirurgica.
[18] K. Hoang-Xuan,et al. Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] L. Stribinskiene,et al. A phase II study of radiation with concomitant and then sequential temozolomide (TMZ) in patients (pts) with newly diagnosed supratentorial high grade malignant glioma (MG) who have undergone surgery with carmustine (BCNU) wafer insertion , 2005 .
[20] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[21] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[22] Susan M. Chang,et al. Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors. , 2004, International journal of radiation oncology, biology, physics.
[23] Z. Ram,et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. , 2003, Neuro-oncology.
[24] R. McLendon,et al. Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. , 2001, Neuro-oncology.
[25] H Kalimo,et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. , 1997, Neurosurgery.
[26] P. Bucy,et al. American Association of Neurological Surgeons , 1986 .
[27] H. Mehdorn,et al. Localized BCNU chemotherapy and the multimodal management of malignant glioma. , 2009, Current medical research and opinion.
[28] M. Sabel,et al. Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience. , 2008, Current medical research and opinion.
[29] B. Spiegel,et al. Clinical Impact of Adjuvant Chemotherapy in Glioblastoma Multiforme , 2007, CNS drugs.
[30] W. Saltzman,et al. Pharmacokinetics of the Carmustine Implant , 2002, Clinical pharmacokinetics.